IROC Executive Committee (IEC)
The IEC, consisting of the Co-Directors and three key ACR/IROC administrators, will oversee timely accomplishment of administrative activities (eg, grant reports, budgeting, meetings), appropriate administration of the IROC grant, organization of IMC meetings, member adherence to IROC policies and procedures, and development of strategies to address new and innovative studies. It will also provide direction for IROC activities, make decisions based on IMC feedback, resolve member disputes, and lead IMC meetings.
IROC Management Committee (IMC)
The IMC will consist of the six PIs (including the two Co-Directors), four subcommittee chairs (SCs), the three ACR/IROC administrators, and three key IROC staff supervising day-to-day core service implementation. Through continual evaluation of IROC’s core services, it will identify potential issues (eg, workload volume, timeliness of clinical reviews) and strategies for addressing them. IMC’s decision-making process will consider feedback from NCI, the NCTN Groups, and other NCI clinical trial programs. The IMC will also provide guidance and direction for the four IROC SCs.
IROC Advisory Committee (IAC)
The IAC, consisting of representatives of NCTN Groups, Statistical and Data Management Centers, Canadian Collaborating Clinical Trials Network, NCI, an imaging and an RT physicist, and a patient advocate, will meet three times a year with the IMC. These meetings will ensure that the needs of NCTN Groups are being met and that imaging and RT QA processes and data collection methods are adequately addressing clinical trial research needs. Improved and innovative solutions for radiation dosimetry and image data collection and analysis, and IT efforts to harmonize the work processes and data storage will also be the focus of the IAC.